Your tongue could reveal cancer: AI study analyzes 4,100 people
NCT ID NCT04793672
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study collected tongue images and clinical data from 4,100 people—both cancer patients and healthy individuals—to build a database. Researchers plan to use artificial intelligence to analyze tongue features for early cancer screening and diagnosis. The study did not test any treatment, but aims to find new ways to detect cancer non-invasively.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple, non-invasive way to screen for cancer by looking at the tongue.
- What could go wrong
- This is an observational study, not a treatment trial. The results may not lead to a reliable screening tool, and AI models may not work well in real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
Hangzhou, Zhejiang, 310022, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A shield for bone marrow: can a drug stop Chemo's blood cell side effect?
- New imaging agent could sharpen cancer detection
- New drug cocktail aims to stop Chemo-Linked nausea before it starts
- Could a painless electrical patch help cancer patients sleep better after surgery?
- New study aims to predict immunotherapy success in cancer patients
- Cancer combo therapy under the microscope: real-world study launched